nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Irinotecan—colon cancer	0.23	0.306	CbGbCtD
Eprosartan—ABCC2—Vincristine—colon cancer	0.201	0.267	CbGbCtD
Eprosartan—CYP2C9—Capecitabine—colon cancer	0.125	0.166	CbGbCtD
Eprosartan—ABCC2—Methotrexate—colon cancer	0.122	0.162	CbGbCtD
Eprosartan—CYP2C9—Fluorouracil—colon cancer	0.0742	0.0986	CbGbCtD
Eprosartan—ABCC2—bile—colon cancer	0.0207	0.292	CbGeAlD
Eprosartan—AGTR1—endothelium—colon cancer	0.00915	0.129	CbGeAlD
Eprosartan—AGTR1—blood vessel—colon cancer	0.00844	0.119	CbGeAlD
Eprosartan—AGTR1—epithelium—colon cancer	0.00411	0.058	CbGeAlD
Eprosartan—AGTR1—smooth muscle tissue—colon cancer	0.00396	0.0559	CbGeAlD
Eprosartan—AGTR1—renal system—colon cancer	0.00381	0.0538	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—colon cancer	0.00316	0.0447	CbGeAlD
Eprosartan—AGTR1—vagina—colon cancer	0.00276	0.039	CbGeAlD
Eprosartan—ABCC2—renal system—colon cancer	0.00275	0.0389	CbGeAlD
Eprosartan—AGTR1—liver—colon cancer	0.00233	0.0329	CbGeAlD
Eprosartan—ABCC2—digestive system—colon cancer	0.00226	0.0319	CbGeAlD
Eprosartan—AGTR1—lymph node—colon cancer	0.00178	0.0252	CbGeAlD
Eprosartan—ABCC2—liver—colon cancer	0.00168	0.0238	CbGeAlD
Eprosartan—CYP2C9—digestive system—colon cancer	0.0015	0.0213	CbGeAlD
Eprosartan—ABCC2—lymph node—colon cancer	0.00129	0.0182	CbGeAlD
Eprosartan—CYP2C9—liver—colon cancer	0.00112	0.0158	CbGeAlD
Eprosartan—Diabetes mellitus—Capecitabine—colon cancer	0.000888	0.00504	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000888	0.00504	CcSEcCtD
Eprosartan—Polyuria—Capecitabine—colon cancer	0.00088	0.00499	CcSEcCtD
Eprosartan—Swelling—Capecitabine—colon cancer	0.000876	0.00497	CcSEcCtD
Eprosartan—Renal failure—Irinotecan—colon cancer	0.000875	0.00496	CcSEcCtD
Eprosartan—Gastroenteritis—Capecitabine—colon cancer	0.000872	0.00494	CcSEcCtD
Eprosartan—Vascular purpura—Capecitabine—colon cancer	0.000864	0.0049	CcSEcCtD
Eprosartan—Herpes simplex—Methotrexate—colon cancer	0.00086	0.00488	CcSEcCtD
Eprosartan—Neuropathy peripheral—Fluorouracil—colon cancer	0.000835	0.00474	CcSEcCtD
Eprosartan—Urinary tract infection—Fluorouracil—colon cancer	0.000828	0.0047	CcSEcCtD
Eprosartan—Conjunctivitis—Fluorouracil—colon cancer	0.000828	0.0047	CcSEcCtD
Eprosartan—Hot flush—Capecitabine—colon cancer	0.000826	0.00468	CcSEcCtD
Eprosartan—Menopausal symptoms—Capecitabine—colon cancer	0.000819	0.00464	CcSEcCtD
Eprosartan—Atrial fibrillation—Capecitabine—colon cancer	0.000815	0.00462	CcSEcCtD
Eprosartan—Bradycardia—Irinotecan—colon cancer	0.000813	0.00461	CcSEcCtD
Eprosartan—Epistaxis—Fluorouracil—colon cancer	0.000804	0.00456	CcSEcCtD
Eprosartan—Purpura—Capecitabine—colon cancer	0.000802	0.00455	CcSEcCtD
Eprosartan—Rhinitis—Irinotecan—colon cancer	0.000801	0.00454	CcSEcCtD
Eprosartan—Sinusitis—Fluorouracil—colon cancer	0.0008	0.00453	CcSEcCtD
Eprosartan—Arthritis—Capecitabine—colon cancer	0.000795	0.00451	CcSEcCtD
Eprosartan—Cardiac failure—Capecitabine—colon cancer	0.000792	0.00449	CcSEcCtD
Eprosartan—Hyponatraemia—Capecitabine—colon cancer	0.000776	0.0044	CcSEcCtD
Eprosartan—Cystitis noninfective—Methotrexate—colon cancer	0.000774	0.00439	CcSEcCtD
Eprosartan—Osteoarthritis—Capecitabine—colon cancer	0.000773	0.00438	CcSEcCtD
Eprosartan—Visual impairment—Irinotecan—colon cancer	0.00077	0.00437	CcSEcCtD
Eprosartan—Rhinitis—Fluorouracil—colon cancer	0.000767	0.00435	CcSEcCtD
Eprosartan—Cystitis—Methotrexate—colon cancer	0.000765	0.00434	CcSEcCtD
Eprosartan—Migraine—Capecitabine—colon cancer	0.000761	0.00431	CcSEcCtD
Eprosartan—Pharyngitis—Fluorouracil—colon cancer	0.000759	0.00431	CcSEcCtD
Eprosartan—Face oedema—Capecitabine—colon cancer	0.000746	0.00423	CcSEcCtD
Eprosartan—Ataxia—Capecitabine—colon cancer	0.000727	0.00412	CcSEcCtD
Eprosartan—Blood creatinine increased—Capecitabine—colon cancer	0.000724	0.00411	CcSEcCtD
Eprosartan—Chills—Irinotecan—colon cancer	0.000717	0.00406	CcSEcCtD
Eprosartan—Urine output increased—Methotrexate—colon cancer	0.000717	0.00406	CcSEcCtD
Eprosartan—Bladder pain—Methotrexate—colon cancer	0.000717	0.00406	CcSEcCtD
Eprosartan—Orthostatic hypotension—Capecitabine—colon cancer	0.000706	0.004	CcSEcCtD
Eprosartan—Hypokalaemia—Capecitabine—colon cancer	0.000703	0.00399	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000696	0.00395	CcSEcCtD
Eprosartan—Back pain—Vincristine—colon cancer	0.000691	0.00392	CcSEcCtD
Eprosartan—Flatulence—Irinotecan—colon cancer	0.000685	0.00389	CcSEcCtD
Eprosartan—Gastritis—Capecitabine—colon cancer	0.000684	0.00388	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000682	0.00386	CcSEcCtD
Eprosartan—Muscular weakness—Capecitabine—colon cancer	0.000682	0.00386	CcSEcCtD
Eprosartan—Back pain—Irinotecan—colon cancer	0.000673	0.00381	CcSEcCtD
Eprosartan—Muscle spasms—Irinotecan—colon cancer	0.000669	0.00379	CcSEcCtD
Eprosartan—Asthma—Capecitabine—colon cancer	0.000668	0.00379	CcSEcCtD
Eprosartan—Diabetes mellitus—Methotrexate—colon cancer	0.000661	0.00375	CcSEcCtD
Eprosartan—Polyuria—Methotrexate—colon cancer	0.000655	0.00372	CcSEcCtD
Eprosartan—Sweating increased—Capecitabine—colon cancer	0.000651	0.00369	CcSEcCtD
Eprosartan—Angina pectoris—Capecitabine—colon cancer	0.000651	0.00369	CcSEcCtD
Eprosartan—Ill-defined disorder—Irinotecan—colon cancer	0.000645	0.00366	CcSEcCtD
Eprosartan—Bronchitis—Capecitabine—colon cancer	0.000642	0.00364	CcSEcCtD
Eprosartan—Vertigo—Vincristine—colon cancer	0.000641	0.00364	CcSEcCtD
Eprosartan—Malaise—Irinotecan—colon cancer	0.000627	0.00356	CcSEcCtD
Eprosartan—Vertigo—Irinotecan—colon cancer	0.000625	0.00354	CcSEcCtD
Eprosartan—Syncope—Irinotecan—colon cancer	0.000624	0.00354	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Capecitabine—colon cancer	0.000621	0.00352	CcSEcCtD
Eprosartan—Loss of consciousness—Irinotecan—colon cancer	0.000611	0.00347	CcSEcCtD
Eprosartan—Myalgia—Vincristine—colon cancer	0.000608	0.00345	CcSEcCtD
Eprosartan—Cough—Irinotecan—colon cancer	0.000607	0.00344	CcSEcCtD
Eprosartan—Hyperglycaemia—Capecitabine—colon cancer	0.000602	0.00342	CcSEcCtD
Eprosartan—Depression—Capecitabine—colon cancer	0.000594	0.00337	CcSEcCtD
Eprosartan—Renal failure—Capecitabine—colon cancer	0.000585	0.00332	CcSEcCtD
Eprosartan—Discomfort—Irinotecan—colon cancer	0.000585	0.00332	CcSEcCtD
Eprosartan—Neuropathy peripheral—Capecitabine—colon cancer	0.000584	0.00331	CcSEcCtD
Eprosartan—Conjunctivitis—Capecitabine—colon cancer	0.000579	0.00328	CcSEcCtD
Eprosartan—Urinary tract infection—Capecitabine—colon cancer	0.000579	0.00328	CcSEcCtD
Eprosartan—Osteoarthritis—Methotrexate—colon cancer	0.000575	0.00326	CcSEcCtD
Eprosartan—Thrombocytopenia—Vincristine—colon cancer	0.000571	0.00324	CcSEcCtD
Eprosartan—Haematuria—Capecitabine—colon cancer	0.000568	0.00322	CcSEcCtD
Eprosartan—Chest pain—Fluorouracil—colon cancer	0.000567	0.00322	CcSEcCtD
Eprosartan—Myalgia—Fluorouracil—colon cancer	0.000567	0.00322	CcSEcCtD
Eprosartan—Hyperhidrosis—Vincristine—colon cancer	0.000563	0.00319	CcSEcCtD
Eprosartan—Epistaxis—Capecitabine—colon cancer	0.000562	0.00319	CcSEcCtD
Eprosartan—Discomfort—Fluorouracil—colon cancer	0.00056	0.00318	CcSEcCtD
Eprosartan—Shock—Irinotecan—colon cancer	0.000558	0.00317	CcSEcCtD
Eprosartan—Thrombocytopenia—Irinotecan—colon cancer	0.000556	0.00315	CcSEcCtD
Eprosartan—Anorexia—Vincristine—colon cancer	0.000555	0.00315	CcSEcCtD
Eprosartan—Hyperhidrosis—Irinotecan—colon cancer	0.000549	0.00311	CcSEcCtD
Eprosartan—Hypotension—Vincristine—colon cancer	0.000545	0.00309	CcSEcCtD
Eprosartan—Bradycardia—Capecitabine—colon cancer	0.000544	0.00309	CcSEcCtD
Eprosartan—Anorexia—Irinotecan—colon cancer	0.000541	0.00307	CcSEcCtD
Eprosartan—Ataxia—Methotrexate—colon cancer	0.000541	0.00307	CcSEcCtD
Eprosartan—Rhinitis—Capecitabine—colon cancer	0.000536	0.00304	CcSEcCtD
Eprosartan—Thrombocytopenia—Fluorouracil—colon cancer	0.000532	0.00302	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Vincristine—colon cancer	0.000531	0.00301	CcSEcCtD
Eprosartan—Pharyngitis—Capecitabine—colon cancer	0.000531	0.00301	CcSEcCtD
Eprosartan—Tachycardia—Fluorouracil—colon cancer	0.00053	0.00301	CcSEcCtD
Eprosartan—Hypotension—Irinotecan—colon cancer	0.00053	0.00301	CcSEcCtD
Eprosartan—Insomnia—Vincristine—colon cancer	0.000527	0.00299	CcSEcCtD
Eprosartan—Oedema peripheral—Capecitabine—colon cancer	0.000527	0.00299	CcSEcCtD
Eprosartan—Paraesthesia—Vincristine—colon cancer	0.000523	0.00297	CcSEcCtD
Eprosartan—Anorexia—Fluorouracil—colon cancer	0.000518	0.00294	CcSEcCtD
Eprosartan—Visual impairment—Capecitabine—colon cancer	0.000515	0.00292	CcSEcCtD
Eprosartan—Insomnia—Irinotecan—colon cancer	0.000513	0.00291	CcSEcCtD
Eprosartan—Paraesthesia—Irinotecan—colon cancer	0.00051	0.00289	CcSEcCtD
Eprosartan—Hypotension—Fluorouracil—colon cancer	0.000508	0.00288	CcSEcCtD
Eprosartan—Decreased appetite—Vincristine—colon cancer	0.000507	0.00287	CcSEcCtD
Eprosartan—Dyspnoea—Irinotecan—colon cancer	0.000506	0.00287	CcSEcCtD
Eprosartan—Somnolence—Irinotecan—colon cancer	0.000505	0.00286	CcSEcCtD
Eprosartan—Fatigue—Vincristine—colon cancer	0.000502	0.00285	CcSEcCtD
Eprosartan—Dyspepsia—Irinotecan—colon cancer	0.0005	0.00283	CcSEcCtD
Eprosartan—Tinnitus—Capecitabine—colon cancer	0.000498	0.00283	CcSEcCtD
Eprosartan—Constipation—Vincristine—colon cancer	0.000498	0.00283	CcSEcCtD
Eprosartan—Pain—Vincristine—colon cancer	0.000498	0.00283	CcSEcCtD
Eprosartan—Asthma—Methotrexate—colon cancer	0.000497	0.00282	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000495	0.00281	CcSEcCtD
Eprosartan—Decreased appetite—Irinotecan—colon cancer	0.000493	0.0028	CcSEcCtD
Eprosartan—Insomnia—Fluorouracil—colon cancer	0.000492	0.00279	CcSEcCtD
Eprosartan—Fatigue—Irinotecan—colon cancer	0.000489	0.00277	CcSEcCtD
Eprosartan—Paraesthesia—Fluorouracil—colon cancer	0.000488	0.00277	CcSEcCtD
Eprosartan—Constipation—Irinotecan—colon cancer	0.000485	0.00275	CcSEcCtD
Eprosartan—Pain—Irinotecan—colon cancer	0.000485	0.00275	CcSEcCtD
Eprosartan—Dyspnoea—Fluorouracil—colon cancer	0.000485	0.00275	CcSEcCtD
Eprosartan—Somnolence—Fluorouracil—colon cancer	0.000483	0.00274	CcSEcCtD
Eprosartan—Chills—Capecitabine—colon cancer	0.00048	0.00272	CcSEcCtD
Eprosartan—Dyspepsia—Fluorouracil—colon cancer	0.000478	0.00271	CcSEcCtD
Eprosartan—Gastrointestinal pain—Vincristine—colon cancer	0.000477	0.0027	CcSEcCtD
Eprosartan—Decreased appetite—Fluorouracil—colon cancer	0.000472	0.00268	CcSEcCtD
Eprosartan—Feeling abnormal—Irinotecan—colon cancer	0.000468	0.00265	CcSEcCtD
Eprosartan—Pain—Fluorouracil—colon cancer	0.000465	0.00264	CcSEcCtD
Eprosartan—Gastrointestinal pain—Irinotecan—colon cancer	0.000464	0.00263	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Methotrexate—colon cancer	0.000462	0.00262	CcSEcCtD
Eprosartan—Abdominal pain—Vincristine—colon cancer	0.000461	0.00261	CcSEcCtD
Eprosartan—Body temperature increased—Vincristine—colon cancer	0.000461	0.00261	CcSEcCtD
Eprosartan—Flatulence—Capecitabine—colon cancer	0.000459	0.0026	CcSEcCtD
Eprosartan—Back pain—Capecitabine—colon cancer	0.00045	0.00255	CcSEcCtD
Eprosartan—Body temperature increased—Irinotecan—colon cancer	0.000449	0.00254	CcSEcCtD
Eprosartan—Abdominal pain—Irinotecan—colon cancer	0.000449	0.00254	CcSEcCtD
Eprosartan—Feeling abnormal—Fluorouracil—colon cancer	0.000448	0.00254	CcSEcCtD
Eprosartan—Muscle spasms—Capecitabine—colon cancer	0.000447	0.00254	CcSEcCtD
Eprosartan—Depression—Methotrexate—colon cancer	0.000442	0.00251	CcSEcCtD
Eprosartan—Tremor—Capecitabine—colon cancer	0.000436	0.00247	CcSEcCtD
Eprosartan—Renal failure—Methotrexate—colon cancer	0.000436	0.00247	CcSEcCtD
Eprosartan—Ill-defined disorder—Capecitabine—colon cancer	0.000432	0.00245	CcSEcCtD
Eprosartan—Urticaria—Fluorouracil—colon cancer	0.000432	0.00245	CcSEcCtD
Eprosartan—Conjunctivitis—Methotrexate—colon cancer	0.000431	0.00244	CcSEcCtD
Eprosartan—Body temperature increased—Fluorouracil—colon cancer	0.00043	0.00244	CcSEcCtD
Eprosartan—Hypersensitivity—Vincristine—colon cancer	0.000429	0.00243	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—colon cancer	0.000423	0.0024	CcSEcCtD
Eprosartan—Malaise—Capecitabine—colon cancer	0.00042	0.00238	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—colon cancer	0.000418	0.00237	CcSEcCtD
Eprosartan—Vertigo—Capecitabine—colon cancer	0.000418	0.00237	CcSEcCtD
Eprosartan—Hypersensitivity—Irinotecan—colon cancer	0.000418	0.00237	CcSEcCtD
Eprosartan—Asthenia—Vincristine—colon cancer	0.000418	0.00237	CcSEcCtD
Eprosartan—Syncope—Capecitabine—colon cancer	0.000417	0.00237	CcSEcCtD
Eprosartan—Palpitations—Capecitabine—colon cancer	0.000411	0.00233	CcSEcCtD
Eprosartan—Loss of consciousness—Capecitabine—colon cancer	0.000409	0.00232	CcSEcCtD
Eprosartan—Asthenia—Irinotecan—colon cancer	0.000407	0.00231	CcSEcCtD
Eprosartan—Cough—Capecitabine—colon cancer	0.000406	0.0023	CcSEcCtD
Eprosartan—Hypersensitivity—Fluorouracil—colon cancer	0.0004	0.00227	CcSEcCtD
Eprosartan—Diarrhoea—Vincristine—colon cancer	0.000399	0.00226	CcSEcCtD
Eprosartan—Chest pain—Capecitabine—colon cancer	0.000396	0.00225	CcSEcCtD
Eprosartan—Myalgia—Capecitabine—colon cancer	0.000396	0.00225	CcSEcCtD
Eprosartan—Arthralgia—Capecitabine—colon cancer	0.000396	0.00225	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—colon cancer	0.000395	0.00224	CcSEcCtD
Eprosartan—Anxiety—Capecitabine—colon cancer	0.000395	0.00224	CcSEcCtD
Eprosartan—Discomfort—Capecitabine—colon cancer	0.000391	0.00222	CcSEcCtD
Eprosartan—Diarrhoea—Irinotecan—colon cancer	0.000388	0.0022	CcSEcCtD
Eprosartan—Dry mouth—Capecitabine—colon cancer	0.000387	0.0022	CcSEcCtD
Eprosartan—Dizziness—Vincristine—colon cancer	0.000385	0.00219	CcSEcCtD
Eprosartan—Pruritus—Fluorouracil—colon cancer	0.000385	0.00218	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—colon cancer	0.000384	0.00217	CcSEcCtD
Eprosartan—Dizziness—Irinotecan—colon cancer	0.000375	0.00213	CcSEcCtD
Eprosartan—Shock—Capecitabine—colon cancer	0.000374	0.00212	CcSEcCtD
Eprosartan—Diarrhoea—Fluorouracil—colon cancer	0.000372	0.00211	CcSEcCtD
Eprosartan—Thrombocytopenia—Capecitabine—colon cancer	0.000372	0.00211	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—colon cancer	0.000371	0.0021	CcSEcCtD
Eprosartan—Tachycardia—Capecitabine—colon cancer	0.000371	0.0021	CcSEcCtD
Eprosartan—Vomiting—Vincristine—colon cancer	0.000371	0.0021	CcSEcCtD
Eprosartan—Rash—Vincristine—colon cancer	0.000367	0.00208	CcSEcCtD
Eprosartan—Hyperhidrosis—Capecitabine—colon cancer	0.000367	0.00208	CcSEcCtD
Eprosartan—Dermatitis—Vincristine—colon cancer	0.000367	0.00208	CcSEcCtD
Eprosartan—Headache—Vincristine—colon cancer	0.000365	0.00207	CcSEcCtD
Eprosartan—Anorexia—Capecitabine—colon cancer	0.000362	0.00205	CcSEcCtD
Eprosartan—Vomiting—Irinotecan—colon cancer	0.000361	0.00205	CcSEcCtD
Eprosartan—Dizziness—Fluorouracil—colon cancer	0.000359	0.00204	CcSEcCtD
Eprosartan—Rash—Irinotecan—colon cancer	0.000358	0.00203	CcSEcCtD
Eprosartan—Dermatitis—Irinotecan—colon cancer	0.000357	0.00203	CcSEcCtD
Eprosartan—Chills—Methotrexate—colon cancer	0.000357	0.00202	CcSEcCtD
Eprosartan—Headache—Irinotecan—colon cancer	0.000356	0.00202	CcSEcCtD
Eprosartan—Hypotension—Capecitabine—colon cancer	0.000355	0.00201	CcSEcCtD
Eprosartan—Nausea—Vincristine—colon cancer	0.000346	0.00196	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000346	0.00196	CcSEcCtD
Eprosartan—Vomiting—Fluorouracil—colon cancer	0.000346	0.00196	CcSEcCtD
Eprosartan—Insomnia—Capecitabine—colon cancer	0.000344	0.00195	CcSEcCtD
Eprosartan—Rash—Fluorouracil—colon cancer	0.000343	0.00194	CcSEcCtD
Eprosartan—Dermatitis—Fluorouracil—colon cancer	0.000342	0.00194	CcSEcCtD
Eprosartan—Paraesthesia—Capecitabine—colon cancer	0.000341	0.00193	CcSEcCtD
Eprosartan—Headache—Fluorouracil—colon cancer	0.00034	0.00193	CcSEcCtD
Eprosartan—Dyspnoea—Capecitabine—colon cancer	0.000339	0.00192	CcSEcCtD
Eprosartan—Nausea—Irinotecan—colon cancer	0.000337	0.00191	CcSEcCtD
Eprosartan—Back pain—Methotrexate—colon cancer	0.000335	0.0019	CcSEcCtD
Eprosartan—Dyspepsia—Capecitabine—colon cancer	0.000334	0.0019	CcSEcCtD
Eprosartan—Decreased appetite—Capecitabine—colon cancer	0.00033	0.00187	CcSEcCtD
Eprosartan—Fatigue—Capecitabine—colon cancer	0.000327	0.00186	CcSEcCtD
Eprosartan—Pain—Capecitabine—colon cancer	0.000325	0.00184	CcSEcCtD
Eprosartan—Constipation—Capecitabine—colon cancer	0.000325	0.00184	CcSEcCtD
Eprosartan—Nausea—Fluorouracil—colon cancer	0.000323	0.00183	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—colon cancer	0.000321	0.00182	CcSEcCtD
Eprosartan—Feeling abnormal—Capecitabine—colon cancer	0.000313	0.00177	CcSEcCtD
Eprosartan—Malaise—Methotrexate—colon cancer	0.000312	0.00177	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—colon cancer	0.000311	0.00177	CcSEcCtD
Eprosartan—Gastrointestinal pain—Capecitabine—colon cancer	0.000311	0.00176	CcSEcCtD
Eprosartan—Cough—Methotrexate—colon cancer	0.000302	0.00171	CcSEcCtD
Eprosartan—Urticaria—Capecitabine—colon cancer	0.000302	0.00171	CcSEcCtD
Eprosartan—Body temperature increased—Capecitabine—colon cancer	0.0003	0.0017	CcSEcCtD
Eprosartan—Abdominal pain—Capecitabine—colon cancer	0.0003	0.0017	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—colon cancer	0.000295	0.00167	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—colon cancer	0.000295	0.00167	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—colon cancer	0.000295	0.00167	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—colon cancer	0.000291	0.00165	CcSEcCtD
Eprosartan—Hypersensitivity—Capecitabine—colon cancer	0.00028	0.00159	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—colon cancer	0.000277	0.00157	CcSEcCtD
Eprosartan—Hyperhidrosis—Methotrexate—colon cancer	0.000273	0.00155	CcSEcCtD
Eprosartan—Asthenia—Capecitabine—colon cancer	0.000273	0.00155	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—colon cancer	0.00027	0.00153	CcSEcCtD
Eprosartan—Pruritus—Capecitabine—colon cancer	0.000269	0.00152	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—colon cancer	0.000264	0.0015	CcSEcCtD
Eprosartan—Diarrhoea—Capecitabine—colon cancer	0.00026	0.00147	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000258	0.00146	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—colon cancer	0.000256	0.00145	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—colon cancer	0.000254	0.00144	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—colon cancer	0.000252	0.00143	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—colon cancer	0.000251	0.00143	CcSEcCtD
Eprosartan—Dizziness—Capecitabine—colon cancer	0.000251	0.00142	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—colon cancer	0.000249	0.00141	CcSEcCtD
Eprosartan—Losartan—ABCB1—colon cancer	0.000246	1	CrCbGaD
Eprosartan—Decreased appetite—Methotrexate—colon cancer	0.000246	0.00139	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—colon cancer	0.000244	0.00138	CcSEcCtD
Eprosartan—Pain—Methotrexate—colon cancer	0.000242	0.00137	CcSEcCtD
Eprosartan—Vomiting—Capecitabine—colon cancer	0.000241	0.00137	CcSEcCtD
Eprosartan—Rash—Capecitabine—colon cancer	0.000239	0.00136	CcSEcCtD
Eprosartan—Dermatitis—Capecitabine—colon cancer	0.000239	0.00136	CcSEcCtD
Eprosartan—Headache—Capecitabine—colon cancer	0.000238	0.00135	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—colon cancer	0.000233	0.00132	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—colon cancer	0.000231	0.00131	CcSEcCtD
Eprosartan—Nausea—Capecitabine—colon cancer	0.000226	0.00128	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—colon cancer	0.000225	0.00127	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—colon cancer	0.000224	0.00127	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—colon cancer	0.000224	0.00127	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—colon cancer	0.000208	0.00118	CcSEcCtD
Eprosartan—Asthenia—Methotrexate—colon cancer	0.000203	0.00115	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—colon cancer	0.0002	0.00113	CcSEcCtD
Eprosartan—Diarrhoea—Methotrexate—colon cancer	0.000193	0.0011	CcSEcCtD
Eprosartan—Dizziness—Methotrexate—colon cancer	0.000187	0.00106	CcSEcCtD
Eprosartan—Vomiting—Methotrexate—colon cancer	0.00018	0.00102	CcSEcCtD
Eprosartan—Rash—Methotrexate—colon cancer	0.000178	0.00101	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—colon cancer	0.000178	0.00101	CcSEcCtD
Eprosartan—Headache—Methotrexate—colon cancer	0.000177	0.001	CcSEcCtD
Eprosartan—Nausea—Methotrexate—colon cancer	0.000168	0.000952	CcSEcCtD
